Loading...
XSHG
600085
Market cap4.67bUSD
Jul 10, Last price  
23.68CNY
1D
2.42%
1Q
-14.82%
Jan 2017
-24.47%
Name

Beijing Tongrentang Co Ltd

Chart & Performance

D1W1MN
XSHG:600085 chart
P/E
27.31
P/S
1.88
EPS
0.87
Div Yield, %
2.16%
Shrs. gr., 5y
—
Rev. gr., 5y
6.11%
Revenues
17.26b
-7.21%
2,396,505,1762,702,850,9392,939,049,5113,250,219,8843,824,446,1416,108,383,7117,516,760,6798,714,647,4019,685,867,52210,896,522,19212,090,740,12113,375,966,34314,208,636,44613,277,123,19812,825,879,05014,603,100,73915,372,423,36317,860,891,45518,597,281,60417,256,185,123
Net income
1.19b
-22.07%
156,021,181232,891,142258,946,471285,610,659343,233,607438,066,654570,060,709656,013,734763,669,177875,437,881933,165,3961,017,381,5561,134,283,852985,435,9131,031,440,9221,227,372,8261,427,334,8981,668,834,5151,526,274,9311,189,374,360
CFO
2.69b
+253.87%
384,559,921121,020,805422,789,931627,689,915492,043,803544,905,320873,968,414676,398,667696,013,987832,472,8451,045,766,4821,448,915,1621,928,378,9942,273,710,5392,174,631,6633,426,414,5633,094,296,2841,869,491,851760,985,2722,692,870,707
Dividend
Jun 30, 20250.5 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Beijing Tongrentang Co., Ltd engages in the production and sale of traditional Chinese medicine preparations in China and internationally. The company offers various product dosage forms, such as pills, powders, medicated wines, capsules, oral liquids, and drop pills. Its products are used for cardiovascular, cerebrovascular, gynecology, heat-clearing, respiratory system, nourishing and calming, digestive, pediatrics, wind-dispelling and dampness removing, orthopedics, facial features, dermatological surgery, mental health, and food and beverages applications. The company was founded in 1997 and is based in Beijing, China. Beijing Tongrentang Co., Ltd operates as a subsidiary of China Beijing Tong Ren Tang Group Co. Ltd.
URL
https://gf.tongrentang.com/
IPO date
Jun 25, 1997
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT